First Time Loading...

Morpho Inc
TSE:3653

Watchlist Manager
Morpho Inc Logo
Morpho Inc
TSE:3653
Watchlist
Price: 1 782 JPY -0.5% Market Closed
Updated: May 11, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

3.6B
-3%
Assets
Growth Rates:
1 Year
-1%
3 Years
-32%
5 Years
-38%
7 Years
-14%
10 Years
+124%
537.4m
-4%
Liabilities
Growth Rates:
1 Year
+7%
3 Years
+49%
5 Years
+84%
7 Years
+103%
10 Years
+116%
3B
-3%
Equity
Growth Rates:
1 Year
-2%
3 Years
-37%
5 Years
-44%
7 Years
-22%
10 Years
+126%

Balance Sheet Decomposition
Morpho Inc

3.6B
Assets
537.4m
Liabilities
3.6B
Assets
537.4m
Liabilities
Current Assets 3.2B
Cash & Short-Term Investments 2.6B
Receivables 453.1m
Other Current Assets 126.2m
Non-Current Assets 390.8m
Long-Term Investments 253.9m
PP&E 48.7m
Intangibles 46.9m
Other Non-Current Assets 41.3m
Current Liabilities 494.4m
Accounts Payable 118.2m
Accrued Liabilities 51.6m
Other Current Liabilities 324.6m
Non-Current Liabilities 43m
Other Non-Current Liabilities 43m

Balance Sheet
Morpho Inc

Rotate your device to view
Balance Sheet
Currency: JPY
Oct-2014 Oct-2015 Oct-2016 Oct-2017 Oct-2018 Oct-2019 Oct-2020 Oct-2021 Oct-2022 Oct-2023
Assets
Cash & Cash Equivalents
1 308
2 036
3 100
3 790
4 325
4 778
4 437
3 392
3 060
2 712
Cash Equivalents
1 308
2 036
3 100
3 790
4 325
4 778
4 437
3 392
3 060
2 712
Total Receivables
520
509
532
555
605
472
277
419
485
517
Accounts Receivables
491
509
532
555
605
472
277
419
485
517
Other Receivables
29
0
0
0
0
0
0
0
0
0
Inventory
4
18
1
1
2
6
8
12
10
34
Other Current Assets
89
90
91
120
53
64
154
255
38
68
Total Current Assets
1 921
2 654
3 725
4 466
4 985
5 320
4 876
4 077
3 593
3 330
PP&E Net
60
69
106
113
114
134
147
126
26
52
PP&E Gross
60
69
106
113
114
134
147
126
26
52
Accumulated Depreciation
73
78
105
143
180
223
275
353
263
243
Intangible Assets
29
24
23
36
46
53
60
45
0
13
Goodwill
0
0
0
0
363
260
0
0
0
0
Note Receivable
0
0
0
0
68
68
68
68
68
62
Long-Term Investments
0
9
22
22
22
22
172
166
193
267
Other Long-Term Assets
62
187
187
177
249
264
70
68
19
16
Other Assets
0
0
0
0
363
260
0
0
0
0
Total Assets
2 072
N/A
2 943
+42%
4 064
+38%
4 815
+18%
5 848
+21%
6 121
+5%
5 393
-12%
4 550
-16%
3 860
-15%
3 707
-4%
Liabilities
Accounts Payable
14
19
14
19
27
37
41
109
127
95
Accrued Liabilities
15
25
16
16
43
57
27
18
24
57
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
47
28
25
17
9
0
1
13
13
14
Other Current Liabilities
234
474
200
235
284
237
183
222
289
343
Total Current Liabilities
311
546
254
287
363
331
252
362
453
509
Long-Term Debt
75
50
26
9
0
2
0
9
0
22
Deferred Income Tax
3
0
0
0
0
0
0
0
5
24
Minority Interest
0
0
0
0
2
7
6
0
0
0
Other Liabilities
20
20
27
34
28
28
30
29
3
4
Total Liabilities
409
N/A
617
+51%
307
-50%
330
+7%
393
+19%
368
-6%
289
-22%
400
+39%
461
+15%
559
+21%
Equity
Common Stock
868
893
1 518
1 519
1 771
1 773
1 774
1 784
1 784
1 784
Retained Earnings
42
565
1 073
1 488
1 953
2 293
1 641
847
189
111
Additional Paid In Capital
817
841
1 467
1 468
1 720
1 722
1 723
1 733
1 733
1 733
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
12
54
Treasury Stock
0
0
315
11
11
11
11
210
371
371
Other Equity
19
27
14
21
21
24
22
4
53
60
Total Equity
1 663
N/A
2 326
+40%
3 757
+62%
4 485
+19%
5 455
+22%
5 753
+5%
5 105
-11%
4 150
-19%
3 399
-18%
3 149
-7%
Total Liabilities & Equity
2 072
N/A
2 943
+42%
4 064
+38%
4 815
+18%
5 848
+21%
6 121
+5%
5 393
-12%
4 550
-16%
3 860
-15%
3 707
-4%
Shares Outstanding
Common Shares Outstanding
5
5
5
5
5
5
5
5
5
5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.